Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis
Annadurai Anandhan, Matthew Dodson, Cody J. Schmidlin, et al.
Cell chemical biology (2020) Vol. 27, Iss. 4, pp. 436-447
Open Access | Times Cited: 315

Showing 1-25 of 315 citing articles:

Ferroptosis: mechanisms, biology and role in disease
Xuejun Jiang, Brent R. Stockwell, Marcus Conrad
Nature Reviews Molecular Cell Biology (2021) Vol. 22, Iss. 4, pp. 266-282
Open Access | Times Cited: 4340
Ferroptosis: molecular mechanisms and health implications
Daolin Tang, Xin Chen, Rui Kang, et al.
Cell Research (2020) Vol. 31, Iss. 2, pp. 107-125
Open Access | Times Cited: 2563
Broadening horizons: the role of ferroptosis in cancer
Xin Chen, Rui Kang, Guido Kroemer, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 280-296
Closed Access | Times Cited: 2012
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Pranavi Koppula, Li Zhuang, Boyi Gan
Protein & Cell (2020) Vol. 12, Iss. 8, pp. 599-620
Open Access | Times Cited: 1517
Targeting ferroptosis as a vulnerability in cancer
Guang Lei, Li Zhuang, Boyi Gan
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 381-396
Open Access | Times Cited: 1403
Ferroptosis: machinery and regulation
Xin Chen, Jingbo Li, Rui Kang, et al.
Autophagy (2020) Vol. 17, Iss. 9, pp. 2054-2081
Open Access | Times Cited: 1336
Cellular degradation systems in ferroptosis
Xin Chen, Chunhua Yu, Rui Kang, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 4, pp. 1135-1148
Open Access | Times Cited: 442
Signaling pathways and defense mechanisms of ferroptosis
Jiao Liu, Rui Kang, Daolin Tang
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 7038-7050
Open Access | Times Cited: 412
Ferroptosis in cancer and cancer immunotherapy
Lei Zhao, Xiaoxue Zhou, Feng Xie, et al.
Cancer Communications (2022) Vol. 42, Iss. 2, pp. 88-116
Open Access | Times Cited: 411
A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers
Pranavi Koppula, Guang Lei, Yilei Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 281
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen, Herbert J. Zeh, Rui Kang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 804-823
Closed Access | Times Cited: 242
NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8
Annadurai Anandhan, Matthew Dodson, Aryatara Shakya, et al.
Science Advances (2023) Vol. 9, Iss. 5
Open Access | Times Cited: 230
GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
Wang Qiujie, Bin Cheng, Qiang Xue, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 217
NUPR1 is a critical repressor of ferroptosis
Jiao Liu, Xinxin Song, Feimei Kuang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 195
Ferroptosis and its emerging roles in cardiovascular diseases
Ning Li, Wenyang Jiang, Wei Wang, et al.
Pharmacological Research (2021) Vol. 166, pp. 105466-105466
Closed Access | Times Cited: 194
Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 165
MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells
Feimei Kuang, Jiao Liu, Yangchun Xie, et al.
Cell chemical biology (2021) Vol. 28, Iss. 6, pp. 765-775.e5
Open Access | Times Cited: 145
Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1/Nrf2 Signaling Pathway Activation
Danlei Li, Xiaoman Liu, Wenhu Pi, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 144
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Nidhi Jyotsana, Kenny T. L. Ta, Kathleen E. DelGiorno
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 142
Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model
Zhuo Pei, Yifei Qin, Xianghui Fu, et al.
Redox Biology (2022) Vol. 57, pp. 102509-102509
Open Access | Times Cited: 132
Knowledge Domain and Emerging Trends in Ferroptosis Research: A Bibliometric and Knowledge-Map Analysis
Jie Zhang, Luxia Song, Liyan Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 127
Hydrogen sulfide alleviates particulate matter-induced emphysema and airway inflammation by suppressing ferroptosis
Ying Wang, Sha Liao, Zihan Pan, et al.
Free Radical Biology and Medicine (2022) Vol. 186, pp. 1-16
Open Access | Times Cited: 123
Iron Accumulation and Lipid Peroxidation in the Aging Retina: Implication of Ferroptosis in Age-Related Macular Degeneration
Tantai Zhao, Xiaojian Guo, Yun Sun
Aging and Disease (2021) Vol. 12, Iss. 2, pp. 529-529
Open Access | Times Cited: 120
A Ferrocene‐Functionalized Covalent Organic Framework for Enhancing Chemodynamic Therapy via Redox Dyshomeostasis
Lele Zhou, Qun Guan, Wen‐Yan Li, et al.
Small (2021) Vol. 17, Iss. 32
Closed Access | Times Cited: 116
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
Guang Lei, Li Zhuang, Boyi Gan
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 513-534
Open Access | Times Cited: 108
Page 1 - Next Page

Scroll to top